Menu
Search Close

News

Issue of Equity

19th December 2008

The Directors of Scancell are pleased to announce that on 19 December 2008, the Company issued 73,333 new ordinary shares of 1p each in lieu of advisory fees relating to the admission of the Company onto the PLUS-quoted market at a price of 60 pence per share.

The trading of the new ordinary shares on PLUS is expected to commence on 22 December 2008.

Following the issue of shares as detailed above the total number of ordinary shares in issue as at 19 December 2008 will be 10,275,551 ordinary shares. The total Directors' Shareholding as a result of the Issue of Equity is 2,627,892 ordinary shares representing 25.57% of the current issued share capital.

The Directors of the issuer accept responsibility for this announcement.

Webcasts, Interviews and Media Coverage

Scancell Holdings wins Japanese patent protection

It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia

Mon, 08 Apr 2019 08:20:00

Scancell strengthens IP with two “important” patent grants in US and Europe

The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88

Wed, 20 Mar 2019 07:55:00

Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise

The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise

Tue, 12 Feb 2019 15:07:00